|Articles|May 1, 2012
- Pharmaceutical Executive-05-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - May 2012
Marooned at the Top
Advertisement
Articles in this issue
over 13 years ago
Pharma 50 Comment: Seeding Beyond the Baseover 13 years ago
Value-Based Pricing: Too High a Price for UK Pharma?over 13 years ago
Pharm Exec 50: Growth from the Bottom Upover 13 years ago
Country Report: South Africaover 13 years ago
Managing Information Overloadover 13 years ago
Super-Size Me: Optimizing the Information Explosionover 13 years ago
Government: Big Pharma's Best Friend in Emerging Markets?over 13 years ago
Information Overloadover 13 years ago
Pharma's Winning Innovative TechnologyNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
